A new approach to tumescent anesthesia.
Solutio™ is an investigational catheter being developed to deliver tumescent solution from within the target vein during endovenous thermal ablation.
Endovenous ablation has evolved. Tumescent delivery largely hasn’t.
Thermal ablation is performed from inside the vein. Yet tumescent anesthesia commonly involves repeated ultrasound-guided percutaneous access along the treatment segment.
What if tumescence could be approached from within the vein?
Solutio is being developed to deliver tumescent solution from within the target vein into the surrounding perivascular space.
Precision by design.
A closer look at the Solutio injector.
Designed to work together.
The injector and treatment fiber in a detailed product view.
A different perspective on precision
Exploring the injector and treatment fiber in an alternative configuration.
Control starts with design
A closer look at the Solutio handle and its integrated controls.
Designed for a familiar step.
Explore the intended delivery concept in three stages.
Position.
Solutio is positioned within the target vein alongside the thermal device.
Deliver
Under ultrasound guidance, the integrated needle is directed through the vessel wall. Tumescent solution is delivered into the perivascular space.
Advance.
The catheter can be repositioned along the treatment segment.
One procedure.
A different approach to access.
Percutaneous access
Access through the skin, with repeated positioning along the treatment segment.
From within the vein
Investigational intravascular approach to delivering tumescence into the perivascular space.
Small device. Significant design consideration.
Every product detail is considered as part of the intended clinical workflow.
Designed around
the procedure.
Patient experience
Designed to reduce reliance on multiple percutaneous needle punctures.
Procedure delivery
An endovascular approach to delivering tumescence around the treatment vein.
Workflow integration
Designed around established thermal ablation workflows.
From innovation
to clinical evidence.
MedVasc is advancing a clinical program designed to evaluate the use of Solutio for intravascular delivery of tumescent anesthesia.
DEVELOPMENT PATH
Illustrative stages — current status to be confirmed
- 01
Concept
- 02
Preclinical
- 03
Clinical
- 04
Regulatory
Evidence first.
Progress with purpose.
The website will evolve as verified study details, publications and regulatory milestones become available. No clinical outcome claims are presented here.
Innovation can happen in the steps we take for granted.
Solutio originated from a clinical observation: while endovenous treatment had evolved, the approach to delivering tumescence remained largely unchanged. MedVasc was founded to explore a different approach.
Dr. Michael Åkesson
Founder, MedVasc
Built with experience in venous intervention.
Karin Ludwigs, MD
Cathrin Johansson
Michael Åkesson, MD
Follow our progress.
News and clinical-development updates will be shared as they become available and are approved for publication.
Interested
in Solutio?
We’re engaging with clinicians, researchers and partners as we advance the development of Solutio.
- Clinicians
- Research Partners
- Strategic Partners
- Media